BRIACELL THERAP EBIT Growth

EBIT Growth of BCTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT Growth growth rates and interactive chart.


Highlights and Quick Summary

  • EBIT Growth for the quarter ending October 31, 2022 was -1.36 (a -16.94% decrease compared to previous quarter)
  • Year-over-year quarterly EBIT Growth decreased by -93.07%
  • Annual EBIT Growth for 2022 was -1.19 (a 54.59% increase from previous year)
  • Annual EBIT Growth for 2021 was -0.77 (a -576.1% decrease from previous year)
  • Annual EBIT Growth for 2020 was 0.16 (a -179.91% decrease from previous year)
  • Twelve month EBIT Growth ending October 31, 2022 was -1.07 (a -9.97% decrease compared to previous quarter)
  • Twelve month trailing EBIT Growth decreased by -80.82% year-over-year
Trailing EBIT Growth for the last four month:
31 Oct '22 31 Jul '22 30 Apr '22 31 Jan '22
-1.07 -1.19 -1.04 -5.59
Visit stockrow.com/BCTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT Growth of BRIACELL THERAP

Most recent EBIT Growthof BCTX including historical data for past 10 years.

Interactive Chart of EBIT Growth of BRIACELL THERAP

BRIACELL THERAP EBIT Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -1.36 -1.64 -0.01 -19.69 -1.19
2021 -5.01 -0.91 -8.5 0.87 -0.77
2020 0.67 0.28 0.55 -0.01 0.16
2019 -0.18 0.22 -0.01 -0.81 -0.2
2018 -0.91 -0.71 -0.27 -1.35 -0.61
2017 -0.56 -2.33 -2.35 0.58 -0.47
2016 -0.07 0.23 0.3 0.62 0.42
2015 -4.61 -1.0 -2.78 -22.87 -5.36
2014 0.32 -0.73 0.16 0.22 -0.03
2013 0.24 0.32 -0.06 0.22 0.21
2012 0.29 0.71 0.52 0.24 0.46

Business Profile of BRIACELL THERAP

Sector: Healthcare
Industry: Biotechnology